Explain How Meds for Postmenopausal Osteoporosis Stack Up

The plethora of med options will raise questions about how to treat postmenopausal osteoporosis...especially with conflicting guidelines.

Which med should be used first? Stick with oral alendronate for most patients. It's about $60/year...versus $1,700 for risedronate.

If patients can't take an oral bisphosphonate, suggest once-yearly IV zoledronic acid (Reclast). It's about $270/year plus infusion costs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote